News
All NewsBlogs
Media
All VideosCase-Based Roundtable SeriesEichenbaum AcornsExpert InterviewsEyeviewsInsightsMedical World NewsPodcastsRapid ReadoutsThe Retina TL;DRViewpoints
Conference
Conference CoverageConference Listing
Publications
Modern Retina Digital EditionSupplements And Featured Publications
More
Resources
Between the LinesCME/CEEYLEA 8mg for nAMD and DME TreatmentSponsored Resources
Partners

Subscribe

  • News
  • Media
  • Conference
  • Publications
  • Resources
  • Partners
  • Subscribe
  • AMD
    • Wet AMD
  • Biosimilar
  • Diabetic Macular Edema
    • Diabetic Eye Awareness
  • Diabetic Retinopathy
  • Geographic Atrophy
  • Imaging
  • Inherited Retinal Diseases
  • Ophthalmology
    • Europe
  • RVO
  • Retina Technology
  • Retinal Surgery
  • Uveitis
Spotlight -
Geographic Atrophy
Advertisement

Asad Loya, MD

Advertisement

Articles by Asad Loya, MD

Social factors associated with diabetic retinopathy visit adherence

ByArash Delavar, MD, MPH,Amer Fadel Alsoudi, MD,Asad Loya, MD,Christina Y. Weng, MD, MBA, FASRS
September 16th 2024

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Modern Retina

    1

    FLORetina 2025: AI at the forefront of ROP care

    2

    AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives

    3

    Prevent Blindness delegates first week of December as 5th annual geographic atrophy week

    4

    EYDENZELT, Celltrion’s biosimilar referencing EYLEA, approved in Canada

    5

    FLORetina 2025: Fibrosis, a limiting factor in visual acuity outcomes in neovascular AMD

    • About
    • Advertise
    • Editorial
    • Contact Us
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us